100 Federal Register / Vol. 89, No. 1 / Tuesday, January 2, 2024 / Notices 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0007. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Registrant Record of Controlled 

Substances Destroyed. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: DEA From 41. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Private 

Sector—business or other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. 

Abstract: In accordance with the 

Controlled Substance Act (CSA), every 

DEA registrant must make a biennial 

inventory and maintain, on a current 

basis, a complete and accurate record of 

each controlled substance 

manufactured, received, sold, delivered, 

or otherwise disposed of. 21 U.S.C. 827 

and 958. These records must be 

maintained separately from all other 

records of the registrant or, 

alternatively, in the case of non-narcotic 

controlled substances, be in such form 

that required information is readily 

retrievable from the ordinary business 

records of the registrant per 21 U.S.C. 

827(b)(2). The records must be kept and 

be available for at least two years for 

inspection and copying by officers or 

employees of the United States 

authorized by the Attorney General. 21 

U.S.C. 827(b)(3). The records must be in 

accordance with and contain such 

relevant information as may be required 

by regulations promulgated by DEA. 21 

U.S.C. 827(b)(1). These record 

requirements help to deter and detect 

diversion of controlled substances and 

ensure that registrants remain 

accountable for all controlled 

substances within their possession and/ 

or control. 

5. Obligation to Respond: Mandatory 

per 21 CFR 1314. 

6. Total Estimated Number of 

Respondents: 92,832. 

7. Estimated Time per Respondent: 30 

minutes for DEA Form 41. 

8. Frequency: DEA Form 41 is 1 per 

year. 

9. Total Estimated Annual Time 

Burden: 46,416 hours. 

10. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218, Washington, DC 20530. 

Dated: December 27, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–28816 Filed 12–29–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0046] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; SelfCertification, Training, and Logbooks 

for Regulated Sellers and Mail-Order 

Distributors of Scheduled Listed 

Chemicals Products 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register on 

October 26, 2023, allowing for a 60-day 

comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

February 1, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

DPW@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0046. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 1 / Tuesday, January 2, 2024 / Notices 101 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: SelfCertification, Training, and Logbooks for 

Regulated Sellers and Mail-Order 

Distributors of Scheduled Listed 

Chemical Products. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: DEA From 597. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Private 

Sector—business or other for-profit. Affected public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. Abstract: The Combat 

Methamphetamine Epidemic Act of 

2005 (CMEA), which is Title VII of the 

USA PATRIOT Improvement and 

Reauthorization Act of 2005 (Pub. L. 

109–177), requires that on and after 

September 30, 2006, a regulated seller 

must not sell at retail over-the-counter 

(non-prescription) products containing 

the List I chemicals ephedrine, 

pseudoephedrine, or 

phenylpropanolamine, unless it has 

self-certified to DEA, through DEA’s 

website. The Methamphetamine 

Production Prevention Act of 2008 

(MPPA) (Pub. L. 110–415) was enacted 

in 2008 to clarify the information entry 

and signature requirements for 

electronic logbook systems permitted for 

the retail sale of scheduled listed 

chemical products. 

5. Obligation to Respond: Mandatory 

21 CFR 1314. 

6. Total Estimated Number of 

Respondents: 20,467,641. 

7. Estimated Time per Respondent: 3 

minutes for Training Record, 15 minutes 

for Self-Certification, and 1 minute for 

Transaction Record (regulated seller) 

and Transaction Record (customer). 

8. Frequency: Training Record is 

13.200, Transaction Record (regulated 

seller) is 395.975, and Transaction 

record (customer) and Self-certification 

are 1.000. 

9. Total Estimated Annual Time 

Burden: 727,455 hours. 

10. Total Estimated Annual Other 

Costs Burden: $157,279. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218, Washington, DC 20530. 

Dated: December 27, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–28818 Filed 12–29–23; 8:45 am] 

BILLING CODE 4410–09–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 50–255; NRC–2023–0200] 

Holtec Decommissioning International, 

LLC, and Holtec Palisades, LLC; 

Palisades Nuclear Plant; Exemption 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Notice; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has issued an 

exemption in response to a request from 

Holtec Decommissioning International, 

LLC (HDI), an indirect wholly owned 

subsidiary of Holtec International, that 

would allow HDI and Holtec Palisades, 

LLC, regarding certain emergency 

planning (EP) requirements. The 

exemption eliminates the requirements 

to maintain an offsite radiological 

emergency preparedness plan and 

reduce the scope of onsite EP activities 

at the Palisades Nuclear Plant, based on 

the reduced risks of accidents that could 

result in an offsite radiological release at 

a decommissioning nuclear power 

reactor. 

DATES: The exemption was issued on 

December 22, 2023. 

ADDRESSES: Please refer to Docket ID 

NRC–2023–0200 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: • Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2023–0200. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. • NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, at 

301–415–4737, or by email to 

PDR.Resource@nrc.gov. The ADAMS 

accession number for each document 

referenced (if it is available in ADAMS) 

is provided the first time that it is 

mentioned in this document. 

• NRC’s PDR: The PDR, where you 

may examine and order copies of 

publicly available documents, is open 

by appointment. To make an 

appointment to visit the PDR, please 

send an email to PDR.Resource@nrc.gov 

or call 1–800–397–4209 or 301–415– 

4737, between 8 a.m. and 4 p.m. eastern 

time (ET), Monday through Friday, 

except Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

Tanya E. Hood, Office of Nuclear 

Material Safety and Safeguards, U.S. 

Nuclear Regulatory Commission, 

Washington, DC 20555–0001; telephone: 

301–415–1387; email: Tanya.Hood@

nrc.gov. 

SUPPLEMENTARY INFORMATION: The text of 

the exemption is attached. 

Dated: December 27, 2023. 

For the Nuclear Regulatory Commission. 

Tanya E. Hood, 

Project Manager, Reactor Decommissioning 

Branch, Division of Decommissioning, 

Uranium Recovery and Waste Programs, 

Office of Nuclear Material Safety and 

Safeguards. 

Attachment—Exemption 

NUCLEAR REGULATORY 

COMMISSION 

Docket No. 50–255 

Holtec Decommissioning International, 

LLC, and Holtec Palisades, LLC; 

Palisades Nuclear Plant, Exemption 

I. Background 

By letter dated October 19, 2017 

(Agencywide Documents Access and 

Management System (ADAMS) 

Accession No. ML17292A032), Entergy 

Nuclear Operations, Inc. (ENOI) 

certified to the U.S. Nuclear Regulatory 

Commission (NRC, or Commission) that 

it planned to permanently cease power 

operations at the Palisades Nuclear 

Plant (Palisades) no later than May 31, 

2022. On May 20, 2022, ENOI 

permanently ceased power operations at 

Palisades, and by letter dated June 13, 

2022 (ML22164A067), ENOI certified to 

the NRC that the fuel was permanently 

removed from the Palisades reactor 

vessel and placed in the spent fuel pool 

(SFP) on June 10, 2022. 

By application dated December 23, 

2020 (ML20358A075), as supplemented 


khammond on DSKJM1Z7X2PROD with NOTICES